Communiqués CannaPharmaRX, Inc.

Actions

CPMD

US13765D1090

Installations et services en soins de santé

Marché Fermé - OTC Markets Autres places de cotation 17:27:29 10/07/2026			Varia. 5j.	Varia. 1 janv.
0,002300 ^USD	0,00%		0,00%	-55,77%

20/05	CannaPharmaRX, Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
31/03	CannaPharmaRX, Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Communiqués

06/05/25	CannapharmaRx Continues into New European Market with First Shipment Completed to Germany	AQ
23/06/23	CANNAPHARMARX, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
22/12/22	Canadian Cannabis; Down but Far from Out - Growth for 2023 and Beyond	NE
21/12/22	CannaPharmaRx Receives Cultivation License from Health Canada and Projects 2023 Revenue Over $30 Million	AQ
21/11/22	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
22/08/22	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
23/05/22	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
15/04/22	CANNAPHARMARX, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
16/02/22	CANNAPHARMARX, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
15/11/21	CANNAPHARMARX, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/08/21	CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/07/21	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure (form 8-K)	AQ
22/06/21	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
09/06/21	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
17/05/21	CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
14/04/21	CANNAPHARMARX : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
28/01/21	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
22/01/21	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
12/01/21	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
12/11/20	CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
20/08/20	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
19/08/20	CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
06/07/20	CANNAPHARMARX, INC. : Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
29/06/20	CANNAPHARMARX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
22/06/20	CANNAPHARMARX : 10-K/A - Management's Discussion and Analysis of Financial Condition and Results of Operations.	AQ